Biomarkers such as leptin, adiponectin, and certain inflammatory cytokines (e.g., IL‐6 and TNF‐α) have shown promise in predicting the risk of obesity and its associated complications. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.